ValuEngine lowered shares of PetMed Express, Inc. (NASDAQ:PETS) from a buy rating to a hold rating in a report issued on Monday morning.

PETS has been the topic of a number of other reports. BidaskClub lowered shares of PetMed Express from a strong-buy rating to a buy rating in a research note on Tuesday, August 22nd. Craig Hallum lowered shares of PetMed Express from a buy rating to a hold rating in a research note on Tuesday, July 11th. Sidoti raised shares of PetMed Express from a neutral rating to a buy rating and set a $47.00 price objective on the stock in a research note on Thursday, August 24th. Noble Financial reaffirmed a hold rating on shares of PetMed Express in a research note on Wednesday, July 26th. Finally, Northcoast Research raised shares of PetMed Express from a neutral rating to a buy rating and set a $54.00 price objective on the stock in a research note on Monday, July 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company. The company presently has an average rating of Hold and an average price target of $40.00.

Shares of PetMed Express (PETS) traded up 1.42% during midday trading on Monday, reaching $35.66. 768,920 shares of the company’s stock traded hands. The stock has a 50 day moving average of $36.58 and a 200-day moving average of $34.70. PetMed Express has a 12 month low of $18.90 and a 12 month high of $50.90. The stock has a market cap of $723.61 million, a P/E ratio of 27.43 and a beta of 1.03.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, July 24th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The firm had revenue of $79.66 million for the quarter, compared to analyst estimates of $77.32 million. During the same period last year, the firm earned $0.32 earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. On average, equities research analysts forecast that PetMed Express will post $1.44 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/10/06/petmed-express-inc-pets-downgraded-to-hold-at-valuengine.html.

In related news, Director Robert C. Schweitzer sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $49.18, for a total transaction of $122,950.00. Following the transaction, the director now directly owns 88,834 shares of the company’s stock, valued at $4,368,856.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the firm’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $50.18, for a total transaction of $342,879.94. Following the transaction, the chief financial officer now directly owns 18,534 shares in the company, valued at $930,036.12. The disclosure for this sale can be found here. Insiders have sold 19,333 shares of company stock worth $949,730 over the last three months. 4.00% of the stock is owned by insiders.

A number of hedge funds have recently made changes to their positions in the business. Pinebridge Investments L.P. raised its position in PetMed Express by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after acquiring an additional 27 shares during the period. Arizona State Retirement System raised its position in PetMed Express by 0.9% in the first quarter. Arizona State Retirement System now owns 10,667 shares of the company’s stock worth $215,000 after acquiring an additional 100 shares during the period. Texas Permanent School Fund raised its position in PetMed Express by 0.8% in the second quarter. Texas Permanent School Fund now owns 14,986 shares of the company’s stock worth $608,000 after acquiring an additional 125 shares during the period. Advisor Group Inc. raised its position in PetMed Express by 0.7% in the second quarter. Advisor Group Inc. now owns 24,844 shares of the company’s stock worth $1,009,000 after acquiring an additional 179 shares during the period. Finally, QS Investors LLC raised its position in PetMed Express by 4.0% in the second quarter. QS Investors LLC now owns 9,324 shares of the company’s stock worth $379,000 after acquiring an additional 356 shares during the period. 78.91% of the stock is currently owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for PetMed Express (NASDAQ:PETS)

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.